medac is a globally operating pharmaceutical company that has been improving patients' quality of life worldwide since 1970. With over 2,000 employees, we generate €620 million in annual turnover and distribute our high-quality pharmaceutical products to more than 90 countries. All our products are manufactured in Germany and Europe to the highest standards, achieving a 98% delivery capability. In the 2023/24 financial year alone, we assembled and packaged 48 million units, including 9 million pens and 10 million syringes, demonstrating our substantial operational scale.
Our mission focuses on four key medical disciplines: rheumatology, urology, hematology, and oncology. We are committed to making essential treatments available worldwide, especially in areas of unmet therapeutic need. As a privately-owned company headquartered in Wedel near Hamburg, we combine expertise, advanced technology, and precision to support patients globally. From product development and production to distribution and marketing, we work tirelessly to provide safe, high-quality original products, generics, biosimilars, and diagnostics that make a tangible difference in human health outcomes.
